Burzwell Pharmaceuticals Private Limited

Burzwell Pharmaceuticals Private Limited - paper in Srinagar, Jammu And Kashmir, India. Directors, charges & compliance details.
CIN U21002JK2023PTC014854 Incorporated 21 July 2023 ROC Jammu HQ Srinagar, Jammu And Kashmir, India
Active Private Limited Company paper
Revenue · FY 2025
₹8.91 Lakh
▲ 78% YoY
Net profit · FY 2025
₹6,619
Net margin 0.7%
EBITDA · FY 2025
₹10,756
EBITDA margin 1.2%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
3 yrs
Est. 2023
Directors on board
2
As per MCA filings
Last financials
Mar 2025
Balance sheet date

About Burzwell Pharmaceuticals Private Limited

Data last updated:

Burzwell Pharmaceuticals Private Limited is a private limited company based in Srinagar, Jammu And Kashmir, India. It operates in the paper and paper products segment of the paper and packaging sector. It was incorporated on 21 July 2023.

The company is registered with the Registrar of Companies (ROC), Jammu, under CIN U21002JK2023PTC014854.

The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Humaira Mukhtar and Mir Mukhtar Ahmad Inayati.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Malikpora, Zainakadal, Srinagar, Jammu and Kashmir, India – 190002.

As per the financials filed for FY 2025, the company reported a revenue of ₹8.91 Lakh, a growth of 78% compared to the previous year. For the same year it recorded a net profit of ₹6,619 (net margin 0.7%) and EBITDA of ₹10,756 (EBITDA margin 1.2%).

Company details

CIN U21002JK2023PTC014854
Registration Number 014854
Incorporation Date 21 July 2023
ROC Jammu
Listing Status Unlisted
Company Status Active

Contact details

Burzwell Pharmaceuticals Private Limited's registered office is in Srinagar, Jammu And Kashmir.

  • Registered Address
    Malikpora, Zainakadal, Srinagar, Jammu and Kashmir, India – 190002
  • Industry
    Paper, Paper & Paper Products, Manufacturing
Comprehensive company report
Burzwell Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Burzwell Pharmaceuticals is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GWholesale and retail trade; repair of motor vehicles and motorcycles46Wholesale trade, except of motor vehicles and motorcycles

To see the full business activity and turnover split of Burzwell Pharmaceuticals Private Limited, buy the company report.

Financials of Burzwell Pharmaceuticals Private Limited

FY 2025 filings available

Burzwell Pharmaceuticals Private Limited reported revenue of ₹8.91 Lakh (up 78% YoY) for FY 2025.

Revenue · FY 2025
₹8.91 Lakh ▲ 78%
Net profit · FY 2025
₹6,619 margin 0.7%
EBITDA · FY 2025
₹10,756 margin 1.2%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 78%
EBITDA CAGR growth
1 year
▼ 7%

Revenue rose 78% in the latest year. EBITDA fell 7% in the latest year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹10,756
Profit Before Tax
Tax Expense
Net Profit (PAT)₹6,619
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24
Profitability
EBITDA Margin1.2%
Net Profit Margin0.7%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Burzwell Pharmaceuticals Private Limited, buy the company report.

Board of directors of Burzwell Pharmaceuticals Private Limited

Burzwell Pharmaceuticals has 2 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Humaira MukhtarDirector21 Jul 20233 Years 4 MonthsCurrent
Mir Mukhtar Ahmad InayatiDirector21 Jul 20233 Years 4 MonthsCurrent

MSME payment delays

No delayed payments to MSME suppliers are on our record for Burzwell Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

No GST registration is on our record for Burzwell Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.

Recent activity

Burzwell Pharmaceuticals Private Limited has 2 board changes on record since 2023: 2 appointments. The latest: Humaira Mukhtar was appointed as Director on 21 Jul 2023.

AGM
Burzwell Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Burzwell Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Jammu.
Appointed
Humaira Mukhtar was appointed as Director.
Appointed
Mir Mukhtar Ahmad Inayati was appointed as Director.
Incorporation
21 Jul 2023
Burzwell Pharmaceuticals Private Limited was registered on 21 Jul 2023 with Roc Jammu & aged 3 years 4 months as per MCA records.

Frequently asked questions

Burzwell Pharmaceuticals is an active private limited company based in Srinagar, Jammu And Kashmir, India. The company works in paper and paper products, within the paper industry. It was incorporated on 21 July 2023 (3+ years old) and is registered under CIN U21002JK2023PTC014854.

Burzwell Pharmaceuticals has 2 current directors:

The latest financial statements of Burzwell Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2024 are in the company report.

The CIN (Corporate Identification Number) of Burzwell Pharmaceuticals is U21002JK2023PTC014854. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Burzwell Pharmaceuticals was incorporated on 21 July 2023, making it 3+ years old. It is registered with the Registrar of Companies, Jammu.

Humaira Mukhtar was appointed as Director on 21 Jul 2023. Mir Mukhtar Ahmad Inayati was appointed as Director on 21 Jul 2023.

The registered office of Burzwell Pharmaceuticals is at Malikpora, Zainakadal, Srinagar, Jammu and Kashmir, India – 190002.

Burzwell Pharmaceuticals operates in the paper industry, in the paper and paper products segment.

Burzwell Pharmaceuticals can be reached at its registered office: Malikpora, Zainakadal, Srinagar, Jammu and Kashmir, India – 190002.

Burzwell Pharmaceuticals is registered under the jurisdiction of the Registrar of Companies (ROC), Jammu.